Joyce DD, Wymer KM, Sharma V, Moriarty JP, et al. Comparative cost-effectiveness of neoadjuvant chemotherapy regimens for muscle-invasive bladder cancer: Results according to VESPER data. Cancer 2022 Oct 17. doi: 10.1002/cncr.34502.
PMID: 36251574